Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antianaphylaxis(antihistamines) and antidotes > Testosterone Base
Testosterone Base
Inquiry
| Post Date: | Aug 12,2015 |
| Expiry Date: | Aug 11,2016 |
| Detailed Description: |
Cas No. :58-22-0
Payment Method: TT/Western union/Money gram Product name:Testosterone Base Other name:Testoviron; Oreton; Testex; Testoderm; Testred; Virilon; Testolent CAS register number:58-22-0 EINECS :200-370-5 Molecular formula:C19H28O2 Molecular weight:288.42 Assay:98% Appearance:White crystalline powder Usage:can be used as pharmaceutical material Product description Purpose: to promote the development of male genitalia and maintain their normal function, for disease-free testosterone replacement therapy, male menopause syndrome, impotence and other diseases Treatment, but also for women of functional uterine bleeding, dysmenorrhea, menorrhagia, aplastic anemia embolism. Usually used and its propionate ester derivatives of benzoic acid. Data presented on June 17, 2013, at the Endocrine Society's 95th Annual Meeting offered positive results regarding the use of testosterone to improve pain tolerance. Narcotic analgesics often lead to lower than normal te stosterone levels in men, thus adding to their perceived pain, as well as contributing to symptoms like irritability and depression. The patents for two well-known and efficacious testosterone treatments. Striant and Testoderm, have patent expirations of August 23, 2019 and November 10, 2019, respectively. The National Institutes of Health states that approximately 5 million American men do not produce enough of the hormone testosterone. Axiron is a highly profitable testosterone replacement therapy, with a patent expiration of February 19, 2017. The testosterone replacement Axiron generated over $48 million dollars in profit in 2011. Coined “The Wittert Study”, after Gary Wittert who is the leader of this study, this novel study is banking on being the first of many to address the worldwide epidemic of type 2 diabetes using testosterone treatment as a preventative. The International Diabetes Federation has stated that the cost to treat type 2 diabetes worldwide now hovers at 471 billion dollars. |
| CAS Registry Number: | 58-22-0 |
| Synonyms: | ;17beta-Hydroxyandrost-4-en-3-one;testosterone-dea schedule iii;testosterone gamma-irradiated cell*culture tested;testosterone cell culture tested--dea*schedule ii;Testosterone;17-hydroxyandrost-4-en-3-one;(17beta)-17-hydroxyandrost-4-en-3-one;(8xi,9xi,14xi,17beta)-17-hydroxyandrost-4-en-3-one;Testosterone Base; |
| Molecular Formula: | C19H28O2 |
| Molecular Weight: | 288.4244 |
| Molecular Structure: | 
|
| Hazard Symbols: |  Xn:Harmful; |
| Risk Codes: | R40:; |
| Safety Description: | S24/25:; |
| Company: | Wuhan Yuancheng Gongchuang Tecnology Co.,Ltd |
| Contact: | Rina |
| Tel: | 02750756038 |
| Fax: | 86-27-88048077-989 |
| Email: | rina@chembj.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
